Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia.

It aims to answer:

* Does sodium supplementation lower the length of hospital stay in children with pneumonia? * Does potassium supplementation lower the length of hospital stay in children with pneumonia?

Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay.

Participants will:

• Take one sachet of oral rehydration solution (ORS) every day for 3 days.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Childhood Pneumonia

Age range

1 month–5 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mataria Teaching Hospital

Cairo, Egypt

About this study

The study is a randomized clinical trial that will be conducted on hospitalized children with pneumonia after considering exclusion criteria.

The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days.

All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Infants and children aged between 1 month and 5 years.
Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.

Exclusion criteria

Children with other comorbidities.
Those whose parents will show disapproval for the participation of the study.
Children on medications that affect sodium and potassium levels.

Treatment and study plan

Oral Rehydration Solution

Dietary Supplement

one sachet every day for 3 days

Primary outcomes

The difference in hospital length of stay between hospitalized children with pneumonia who received oral rehydration solution and those who did not receive it

Time frame: Children will be followed until discharge from the hospital, an average of one week.

Evaluation of effect of oral rehydration solution supplementation by assessing the length of hospital stay

Sponsors and collaborators

Lead sponsor

General Organization for Teaching Hospitals and Institutes

Other

Registry information

Official study title

Impact of Prophylactic Sodium Supplementation on Hospital Outcomes in Infants and Children With Pneumonia. A Randomized Controlled Trial

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Apr 30, 2025
Registry last updated: Sep 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed